Impact of drug interactions, dosage, and duration of therapy on the risk of hip fracture associated with benzodiazepine use in older adults
To determine how concomitant use of potentially interacting drugs, drug dosage, and duration of therapy modify the risk of hip fracture associated with use of benzodiazepines and benzodiazepine-related drugs (BDZ) in older adults.
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
7 October 2010
|
| In: |
Pharmacoepidemiology and drug safety
Year: 2010, Volume: 19, Issue: 12, Pages: 1248-1255 |
| ISSN: | 1099-1557 |
| DOI: | 10.1002/pds.2031 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1002/pds.2031 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/pds.2031 |
| Author Notes: | Kristina Zint, Walter E. Haefeli, Robert J Glynn, Helen Mogun, Jerry Avorn and Til Stürmer |
| Summary: | To determine how concomitant use of potentially interacting drugs, drug dosage, and duration of therapy modify the risk of hip fracture associated with use of benzodiazepines and benzodiazepine-related drugs (BDZ) in older adults. |
|---|---|
| Item Description: | Gesehen am 31.10.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1099-1557 |
| DOI: | 10.1002/pds.2031 |